{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:24:30Z","timestamp":1788827070048,"version":"build-2803163510"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860325"],"award-info":[{"award-number":["860325"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010890","name":"Central People's Government of the People's Republic of China Scholarship Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001592","name":"Higher Education Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.vaccine.2025.127844","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T16:32:07Z","timestamp":1760373127000},"page":"127844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Protective efficacy of two novel Klebsiella pneumoniae vaccine antigens, LysM\/BON and OMPP1, in a murine model"],"prefix":"10.1016","volume":"66","author":[{"given":"Yueran","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Zarodkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julen Tom\u00e1s","family":"Cort\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Stoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00eb","family":"Tulauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guerrino","family":"Macori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Valvano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobh\u00e1n","family":"McClean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2025.127844_bb0005","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1099\/00207713-51-3-915","article-title":"Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping","volume":"51","author":"Brisse","year":"2001","journal-title":"Int J Syst Evol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12866-025-03798-8","article-title":"From soil to surface water: exploring Klebsiella 's clonal lineages and antibiotic resistance odyssey in environmental health","volume":"25","author":"Araujo","year":"2025","journal-title":"BMC Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127844_bb0015","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/14760584.2019.1635460","article-title":"Progress towards the development of Klebsiella vaccines","volume":"18","author":"Choi","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127844_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2025.127844_bb0025","series-title":"ECDC publishes the annual epidemiological report 2019 in Eurosurveillance","author":"ECDC","year":"2019"},{"key":"10.1016\/j.vaccine.2025.127844_bb0030","series-title":"World Health Organization: GLASS report: Early Implementation 2020","author":"WHO","year":"2020"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127844_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad649","article-title":"The global and regional prevalence of hospital-acquired Carbapenem-resistant Klebsiella pneumoniae infection: a systematic review and Meta-analysis","volume":"11","author":"Lin","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","article-title":"Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae","volume":"16","author":"Xu","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.014","article-title":"A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections","volume":"55","author":"Agyeman","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127844_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/CMR.00001-19","article-title":"Hypervirulent Klebsiella pneumoniae","volume":"32","author":"Russo","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127844_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14787210.2019.1555470","article-title":"Hypervirulent Klebsiella pneumoniae: a new public health threat","volume":"17","author":"Marr","year":"2019","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.vaccine.2025.127844_bb0060","series-title":"WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance","author":"WHO","year":"2024"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.101040","article-title":"Impact of vaccines in reducing antimicrobial resistance","volume":"6","author":"Jesudason","year":"2025","journal-title":"The Lancet Microbe"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4161\/hv.34306","article-title":"Hepatitis B vaccination","volume":"11","author":"Roman\u00f2","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"49","key":"10.1016\/j.vaccine.2025.127844_bb0075","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","article-title":"The global impact of vaccination against hepatitis B: a historical overview","volume":"26","author":"Zanetti","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127844_bb0080","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/infdis\/jis178","article-title":"Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010","volume":"205","author":"Octavia","year":"2012","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127844_bb0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","article-title":"The role of vaccines in combatting antimicrobial resistance","volume":"19","author":"Micoli","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127844_bb0090","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S2666-5247(22)00303-2","article-title":"The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline","volume":"4","author":"Frost","year":"2022","journal-title":"The Lancet Microbe"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127844_bb0095","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S2666-5247(21)00064-1","article-title":"Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis","volume":"2","author":"Andrejko","year":"2021","journal-title":"The Lancet Microbe"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127844_bb0100","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s40121-021-00533-4","article-title":"Current stage in the development of Klebsiella pneumoniae vaccines","volume":"10","author":"Assoni","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127844_bb0105","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1128\/IAI.69.10.6434-6444.2001","article-title":"Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein a derived from Klebsiella pneumoniae","volume":"69","author":"Goetsch","year":"2001","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127844_bb0110","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1128\/IAI.67.11.5547-5551.1999","article-title":"Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae","volume":"67","author":"Rauly","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127844_bb0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.micpath.2008.11.006","article-title":"Klebsiella pneumoniae MrkD adhesin-mediated immunity to respiratory infection and mapping the antigenic epitope by phage display library","volume":"46","author":"Li","year":"2009","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2025.127844_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127075","article-title":"In-silico and experimental analysis of Klebsiella pneumoniae fimbriae subunits for vaccine development","volume":"53","author":"Assoni","year":"2025","journal-title":"Vaccine"},{"issue":"19S1","key":"10.1016\/j.vaccine.2025.127844_bb0125","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.vaccine.2024.02.072","article-title":"Vaccine value profile for Klebsiella pneumoniae","volume":"42","author":"Dangor","year":"2024","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127844_bb0130","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0264-410X(94)80054-4","article-title":"Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously","volume":"12","author":"Edelman","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/clinids\/23.1.179","article-title":"Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma","volume":"23","author":"Campbell","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127844_bb0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/infdis\/174.3.537","article-title":"Immunoprophylaxis against Klebsiella and Pseudomonas aeruginosa infections","volume":"174","author":"Donta","year":"1996","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0264-410X(86)90092-7","article-title":"Safety and immunogenicity of a polyvalentKlebsiella capsular polysaccharide vaccine in humans","volume":"4","author":"Cryz","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127844_bb0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/microorganisms8101521","article-title":"Vaccines against Meningococcal Diseases","volume":"8","author":"Pizza","year":"2020","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127844_bb0155","article-title":"Acellular pertussis vaccine components: today and tomorrow","volume":"8","author":"Dewan","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127844_bb0160","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1128\/IAI.01248-15","article-title":"Linocin and OmpW are involved in attachment of the cystic fibrosis-associated pathogen Burkholderia cepacia complex to lung epithelial cells and protect mice against infection","volume":"84","author":"McClean","year":"2016","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/vaccines11010175","article-title":"GlnH, a novel antigen that offers partial protection against Verocytotoxigenic Escherichia coli infection","volume":"11","author":"Quinn","year":"2023","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41541-024-00994-x","article-title":"Proteomic approach to identify host cell attachment proteins provides protective Pseudomonas aeruginosa vaccine antigen FtsZ","volume":"9","author":"Jurado-Mart\u00edn","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2025.127844_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127145","article-title":"The novel antigen, lipopolysaccharide export protein LptH, protects mice against Pseudomonas aeruginosa acute pneumonia in monovalent and multivalent vaccines","volume":"56","author":"Jurado-Mart\u00edn","year":"2025","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127844_bb0180","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/iai.57.2.546-552.1989","article-title":"Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor","volume":"57","author":"Nassif","year":"1989","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127844_bb0185","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1099\/mic.0.2008\/022301-0","article-title":"Capsule polysaccharide is a bacterial decoy for antimicrobial peptides","volume":"154","author":"Llobet","year":"2008","journal-title":"Microbiology"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127844_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165973","article-title":"From proteomic analysis to potential therapeutic targets: functional profile of two lung Cancer cell lines, A549 and SW900, widely studied in pre-clinical research","volume":"11","author":"Korrodi-Gregorio","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0195","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1165\/ajrcmb.10.1.7507342","article-title":"CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells","volume":"10","author":"Cozens","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0200","doi-asserted-by":"crossref","first-page":"e1311","DOI":"10.1002\/mbo3.1311","article-title":"A universal stress protein upregulated by hypoxia has a role in Burkholderia cenocepacia intramacrophage survival: implications for chronic infection in cystic fibrosis","volume":"12","author":"O\u2019Connor","year":"2023","journal-title":"MicrobiologyOpen"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/jcm.27.1.82-87.1989","article-title":"Isolation and characterization of Klebsiella pneumoniae Unencapsulated mutants","volume":"27","author":"Bened\u00ed","year":"1989","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/iai.54.1.85-89.1986","article-title":"Role of capsule and O antigen in resistance of Klebsiella","volume":"54","author":"Tomas","year":"1986","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127844_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080796","article-title":"Immunoproteomic Analysis of Proteins Expressed by Two Related Pathogens, Burkholderia multivorans and Burkholderia cenocepacia, during Human Infection","volume":"8","author":"Shinoy","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127844_bb0220","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","article-title":"In-gel digestion for mass spectrometric characterization of proteins and proteomes","volume":"1","author":"Shevchenko","year":"2006","journal-title":"Nat Protoc"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127844_bb0225","doi-asserted-by":"crossref","DOI":"10.1093\/gbe\/evae166","article-title":"Evolution of the genetic code in the Ascoideales (CUG-Ser2) yeast clade: the ancestral tRNA-Leu(CAG) gene is retained in Most Saccharomycopsis species but is nonessential and not used for translation","volume":"16","author":"O Cinneide","year":"2024","journal-title":"Genome Biol Evol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127844_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050214","article-title":"Outer membrane vesicles from Brucella abortus promote bacterial internalization by human monocytes and modulate their innate immune response","volume":"7","author":"Pollak","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127844_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767359","article-title":"BpOmpW antigen stimulates the necessary protective T-cell responses against Melioidosis","volume":"12","author":"Tom\u00e1s-Cort\u00e1zar","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127844_bb0240","article-title":"Community-acquired infection caused by the uncommon hypervirulent Klebsiella pneumoniae ST66-K2 lineage","volume":"6","author":"Rodrigues","year":"2020","journal-title":"Microb Genom"},{"key":"10.1016\/j.vaccine.2025.127844_bb0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7007-12-41","article-title":"Comparative analysis of Klebsiella pneumoniae genomes identifies a phospholipase D family protein as a novel virulence factor","volume":"12","author":"Lery","year":"2014","journal-title":"BMC Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127844_bb0250","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01733-20","article-title":"Klebsiella pneumoniae reduces SUMOylation to limit host defense responses","volume":"11","author":"Sa-Pessoa","year":"2020","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0255","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1080\/21505594.2021.1960101","article-title":"The hypermucoviscosity of hypervirulent K. pneumoniae confers the ability to evade neutrophil-mediated phagocytosis","volume":"12","author":"Xu","year":"2021","journal-title":"Virulence"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127844_bb0260","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1128\/IAI.70.3.1075-1080.2002","article-title":"Role of lung epithelial cells in defense against Klebsiella pneumoniae pneumonia","volume":"70","author":"Cortes","year":"2002","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127844_bb0265","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/pmic.200500214","article-title":"Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis","volume":"6","author":"Kurupati","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2025.127844_bb0270","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3389\/fmicb.2017.01805","article-title":"Evaluation of recombinant multi-epitope outer membrane protein-based Klebsiella pneumoniae subunit vaccine in mouse model","volume":"8","author":"Babu","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2025.127844_bb0275","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.micpath.2018.04.004","article-title":"Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model","volume":"119","author":"Hussein","year":"2018","journal-title":"Microb Pathog"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127844_bb0280","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/infdis\/jit384","article-title":"Klebsiella pneumoniae peptidoglycan-associated lipoprotein and murein lipoprotein contribute to serum resistance, antiphagocytosis, and proinflammatory cytokine stimulation","volume":"208","author":"Hsieh","year":"2013","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127844_bb0285","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/21505594.2016.1171435","article-title":"The Klebsiella pneumoniae YfgL (BamB) lipoprotein contributes to outer membrane protein biogenesis, type-1 fimbriae expression, anti-phagocytosis, and in vivo virulence","volume":"7","author":"Hsieh","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2025.127844_bb0290","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cellimm.2019.01.006","article-title":"Immunogenicity and protective potential of Bordetella pertussis biofilm and its associated antigens in a murine model","volume":"337","author":"Dorji","year":"2019","journal-title":"Cell Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2025.127844_bb0295","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","article-title":"PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes","volume":"26","author":"Yu","year":"2010","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2567.2011.03517.x","article-title":"T-cell-inducing vaccines - what's the future","volume":"135","author":"Gilbert","year":"2012","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127844_bb0305","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4049\/jimmunol.165.5.2643","article-title":"Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia","volume":"165","author":"Moore","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127844_bb0310","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.4049\/jimmunol.1300039","article-title":"Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia","volume":"192","author":"Xu","year":"2014","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127844_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006696","article-title":"Natural killer cell-intrinsic type I IFN signaling controls Klebsiella pneumoniae growth during lung infection","volume":"13","author":"Ivin","year":"2017","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127844_bb0320","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/cid\/cir007","article-title":"\u201cHerd immunity\u201d: a rough guide","volume":"52","author":"Fine","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2025.127844_bb0325","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1073\/pnas.1704507114","article-title":"Simply put: vaccination saves lives","volume":"114","author":"Orenstein","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"10.1016\/j.vaccine.2025.127844_bb0330","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.vaccine.2016.03.088","article-title":"Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis","volume":"34","author":"Casey","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127844_bb0335","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijbiomac.2020.05.172","article-title":"Interaction of LysM BON family protein domain with carbapenems: a putative mechanism of carbapenem resistance","volume":"160","author":"Ali","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.vaccine.2025.127844_bb0340","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jgar.2016.12.010","article-title":"Proteomic analysis of a carbapenem-resistant Klebsiella pneumoniae strain in response to meropenem stress","volume":"8","author":"Khan","year":"2017","journal-title":"J Global Antimicrob Resist"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127844_bb0345","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/lam.13672","article-title":"Comparison of the outer membrane proteomes between clinical carbapenem-resistant and -susceptible Acinetobacter baumannii","volume":"74","author":"Zhu","year":"2022","journal-title":"Lett Appl Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127844_bb0350","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0968-0004(03)00115-4","article-title":"The BON domain: a putative membrane-binding domain","volume":"28","author":"Yeats","year":"2003","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0355","first-page":"78","article-title":"Screening of the Salmonella paratyphi a CMCC 50973 strain outer membrane proteins for the identification of potential vaccine targets","volume":"5","author":"Yang","year":"2012","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127844_bb0360","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/21645515.2015.1010910","article-title":"Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology","volume":"11","author":"Chiang","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0365","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13567-022-01023-2","article-title":"Immunogenic characteristics of the outer membrane phosphoporin as a vaccine candidate against Klebsiella pneumoniae","volume":"53","author":"Hu","year":"2022","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2025.127844_bb0370","article-title":"Identification and evaluation of recombinant outer membrane proteins as vaccine candidates against Klebsiella pneumoniae","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127844_bb0375","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1165\/ajrcmb.25.3.4424","article-title":"Interleukin-17 and lung host defense against Klebsiella pneumoniae infection","volume":"25","author":"Ye","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127844_bb0380","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.4049\/jimmunol.170.9.4432","article-title":"Cutting edge: roles of toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection","volume":"170","author":"Happel","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.127844_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127837","article-title":"Exploring the journey: a comprehensive review of vaccine development against Klebsiella pneumoniae","volume":"287","author":"Douradinha","year":"2024","journal-title":"Microbiol Res"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127844_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079961","article-title":"Activation of IFN-gamma\/STAT\/IRF-1 in hepatic responses to Klebsiella pneumoniae infection","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"issue":"Supplement_3","key":"10.1016\/j.vaccine.2025.127844_bb0395","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1086\/430126","article-title":"Defective innate antibacterial host responses during murine Klebsiella pneumoniae bacteremia: tumor necrosis factor (TNF) receptor 1 deficiency versus therapy with anti\u2013TNF-\u03b1","volume":"41","author":"Moore","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127844_bb0400","doi-asserted-by":"crossref","first-page":"1050396","DOI":"10.3389\/fcimb.2022.1050396","article-title":"Host defense against the infection of Klebsiella pneumoniae: new strategy to kill the bacterium in the era of antibiotics?","volume":"12","author":"Liang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127844_bb0405","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/femsre\/fuy043","article-title":"Klebsiella pneumoniae infection biology: living to counteract host defences","volume":"43","author":"Bengoechea","year":"2019","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2025.127844_bb0410","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/82_2011_188","article-title":"Bacterial moonlighting proteins and bacterial virulence","volume":"358","author":"Henderson","year":"2011","journal-title":"Between Pathogenicity Commensalism"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127844_bb0415","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1128\/IAI.00179-11","article-title":"Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease","volume":"79","author":"Henderson","year":"2011","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127844_bb0420","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.femsim.2005.01.005","article-title":"Antibodies against human muscle enolase recognize a 45-kDa bacterial cell wall outer membrane enolase-like protein","volume":"45","author":"Witkowska","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2025.127844_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2021.104187","article-title":"The moonlighting protein fructose 1,6-bisphosphate aldolase as a potential vaccine candidate against Photobacterium damselae subsp. piscicida in Asian sea bass (Lates calcarifer)","volume":"124","author":"Pham","year":"2021","journal-title":"Dev Comp Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25011417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25011417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:57:40Z","timestamp":1763693860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25011417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":85,"alternative-id":["S0264410X25011417"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127844","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective efficacy of two novel Klebsiella pneumoniae vaccine antigens, LysM\/BON and OMPP1, in a murine model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127844"}}